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A 16 year old lebanese girl with consanguinous parents
presented with a severe “abdominal” sepsis supposedly
resulting from an infected vaginal tampon (ESBL E.coli).
She had been healthy before. She developed severe hepa-
tic functional disorder, infarction of the spleen, cardio-
vascular and renal insufficiency, as well as anemia and
thrombocytopenia. Macrophage activation syndrome was
diagnosed subsequently and systemic glucocorticoid
treatment initiated. The girl recovered clinically. Of note,
she developed severe cushingoid syndrome. Due to lim-
ited compliance she discontinued all anti-inflammatory
medication (nsaids, gc and ciclosporin) 4 weeks later.
The following 18 months inflammatory parameters were
persistantly elevated (ESR>100mm/h). Familial meditera-
nean fever was excluded. Genetic analysis revealed a
homozygous perforin I gene mutation 91 (GCG) -> Valin
(GTG)/.pAla91Val-/A91V in exon 2. Familial hemopha-
gocytic lymphohistiocytosis type II was discussed as a
potential diagnosis. Perforin expression was diminshed to
about 50% in NK-cells, however functional NK-cell cyto-
toxicity was in the lower normal range, considered not
impaired.
On the basis of these findings, we want to discuss the
role of the homozygous A91V perforin mutation for the
initiation or perpetuation of a life-threatening macrophage
activation syndrome, in addition to the further manage-
ment of the patient.
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